Overview
Jonathan Kurie is an Oncologist in Houston, Texas. Dr. Kurie is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Adenocarcinoma, Lung Cancer, Pleuropulmonary Blastoma, and Non-Small Cell Lung Cancer (NSCLC).
His clinical research consists of co-authoring 89 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 26 articles in the study of Lung Adenocarcinoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
MD Anderson
Lauren Byers is an Oncologist in Houston, Texas. Dr. Byers is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.
MD Anderson
Ferdinandos Skoulidis is an Oncologist in Houston, Texas. Dr. Skoulidis is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).
MD Anderson
Tina Cascone is an Oncologist in Houston, Texas. Dr. Cascone is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Pleuropulmonary Blastoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung AdenocarcinomaDr. Kurie isElite. Learn about Lung Adenocarcinoma.
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Kurie isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Large-Cell Lung CarcinomaDr. Kurie isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung CancerDr. Kurie isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Kurie isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pleuropulmonary BlastomaDr. Kurie isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Kurie isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- EGFR Positive Lung CancerDr. Kurie isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Metastatic Brain TumorDr. Kurie isExperienced. Learn about Metastatic Brain Tumor.
- Metastatic Pleural TumorDr. Kurie isExperienced. Learn about Metastatic Pleural Tumor.
- Neuroendocrine TumorDr. Kurie isExperienced. Learn about Neuroendocrine Tumor.
- Posterior Fossa TumorDr. Kurie isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Thymic Epithelial TumorDr. Kurie isExperienced. Learn about Thymic Epithelial Tumor.